BUY Biocon Ltd — Aastha Jain, Hem Securities
byAastha Jain, Hem SecuritiesHorizon: NA (inferred 1–3 months)17 Aug 2026via Zee Business (Live)
Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.
AI Assessment
Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.
Biocon Biologics Secures Japan Approval for Pegfilgrastim Biosimilar
NewsGoogle News·25 Aug · 2w ago
Biocon arm gets Japan nod for cancer drug pegfilgrastim biosimilar
NewsGoogle News·25 Aug · 2w ago
Vikas Khemani bets big on India's manufacturing shift, sees Biocon at an "inflection point"
NewsCnbc-Tv18·21 Aug · 2w ago
Biocon shares rise 2% after USFDA approval for Yesintek single-dose prefilled autoinjector
NewsEt-Markets·18 Aug · 3w ago
5 advisors have active long-term BUY calls on this stock
Advisor consensus · adjacent horizon·7 Aug · 1mo ago
Buy, Sell Or Hold: IndiGo, Maruti Suzuki, Biocon, LIC, Hindustan Copper, Bharat Dynamics — Ask Profit
NewsNdtv-Profit·2 Sept · 4d ago
Buy, Sell Or Hold: Mahindra & Mahindra, Coforge, TVS Motor, Biocon And Divi's Labs — Ask Profit
NewsNdtv-Profit·30 Aug · 1w ago
Buy, Sell Or Hold: Mazagon Dock, HAL, Biocon, Suzlon And Tata Motors PV — Ask Profit
NewsNdtv-Profit·18 Aug · 3w ago
Biocon shares fall 2.06% in early trade
NewsGoogle News·13 Aug · 4w ago
3 advisors have active long-term SELL calls on this stock
Advisor consensus · adjacent horizon·15 Jul · 2mo ago
Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.
Other calls on Biocon
- BUY — Kunal Bothra22 Oct 2026 · ~2 weeks · target ₹345 · SL hit
- SELL — Rajesh Satpute9 Oct 2026 · ~3 months · target ₹335 · Active
- BUY — Axis Securities19 Sept 2026 · ~3 months · target ₹424 · Active
- BUY — Prakash Gaba17 Sept 2026 · ~2 weeks · target ₹390 · Target hit
- BUY — Vikas Salunkhe, Nirmal Bang Securities27 Aug 2026 · ~2 weeks · target ₹440 · SL hit
More from Aastha Jain, Hem Securities
- BUY Chennai Petroleum Corporation23 Oct 2026 · ~2 weeks · target ₹1,570 · Active
- BUY Zensar Technologies23 Oct 2026 · Next day · target ₹550 · Active
- BUY Tata Consultancy Services23 Oct 2026 · ~2 weeks · target ₹2,600 · Target hit
- BUY Tata Elxsi22 Oct 2026 · Same day · target ₹3,930 · Expired
- BUY The Indian Hotels Company22 Oct 2026 · ~2 weeks · target ₹820 · Active

